Xizang Weixinkang Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, specialising in Contract Development and Manufacturing (CDMO) and finished dosage forms. Established in 2006 as a formally recognised entity and officially listed on the Shanghai Stock Exchange in 2017, the company operates with a robust workforce of nearly 800 employees across 13 subsidiaries.

Services include:
– Contract Development and Manufacturing (CDMO)
– Finished Dosage Forms

Xizang Weixinkang Pharmaceutical Co., Ltd. is dedicated to providing high-quality pharmaceutical solutions, ensuring adherence to industry standards and customer satisfaction. For more information, visit wxkpharma.com.